Glucose and Sucrose Assay Kit |
GWB-AXR286 |
GenWay Biotech |
100 assays |
Ask for price |
Biomarker Assay Laboratories manufactures the biomarker assay portfolio reagents distributed by Genprice. The Biomarker Assay Portfolio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact biomarker assay. Other Biomarker products are available in stock. Specificity: Biomarker Category: Assay Group: Portfolio
CytoSelect Cell Viability and Cytotoxicity Assay |
MyBiosource |
96Assays |
EUR 460 |
Protein stability and aggregation assay kit |
ProFoldin |
200 assays |
EUR 122.41 |
Description: This product includes 60 ul of 1000 x PSA dye for more than 200 assays with the assay volume of 0.3 ml using 96-well plates or cuvettes. |
HDL and LDL/VLDL Assay Kit |
Biochain |
100 assays |
EUR 898 |
Portfolio information
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
MBS4380253-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
MBS4380253-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
MBS4380253-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
MBS4380254-002mgWithBSAAzideat02mgmL |
MyBiosource |
0.02mg(WithBSA&Azideat0.2mg/mL) |
EUR 230 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
MBS4380254-01mgWithBSAAzideat02mgmL |
MyBiosource |
0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 405 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
MBS4380254-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
MBS4380254-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
TIMP1 (Colorectal Cancer Biomarker/Marker of Lymph Node Metastasis) |
MBS4380254-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL |
BNUB2430-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL |
BNUB2430-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 1mg/mL |
BNUM2430-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL |
BNUB2759-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL |
BNUB2759-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL |
BNUB2760-100 |
Biotium |
1uL |
EUR 225 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL |
BNUB2760-500 |
Biotium |
1uL |
EUR 485 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 1mg/mL |
BNUM2759-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 1mg/mL |
BNUM2760-50 |
Biotium |
1uL |
EUR 396 |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |